![]() | |
Identifiers | |
---|---|
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C12H16N2 |
Molar mass | 188.274 g·mol−1 |
3D model (JSmol) | |
| |
|
RJR-2429 is a drug that acts as anagonist at neuralnicotinic acetylcholine receptors, binding to both theα3β4 and theα4β2subtypes. RJR-2429 is stronger thannicotine but weaker thanepibatidine in most assays, and with high affinity for both α3β4 and α4β2 subtypes, as well as the less studied α1βγδ subtype.[1][2][3]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |